{"id":2697,"date":"2020-07-28T04:14:48","date_gmt":"2020-07-28T04:14:48","guid":{"rendered":"http:\/\/www.biosafety.kz\/?p=2697"},"modified":"2020-07-29T12:05:40","modified_gmt":"2020-07-29T12:05:40","slug":"%d0%b2%d0%b8%d0%b4%d0%b5%d0%be%d0%ba%d0%be%d0%bd%d1%84%d0%b5%d1%80%d0%b5%d0%bd%d1%86%d0%b8%d1%8f-%d1%81-%d0%bc%d0%b5%d0%b4%d0%b8%d1%86%d0%b8%d0%bd%d1%81%d0%ba%d0%be%d0%b9-%d1%88%d0%ba%d0%be%d0%bb","status":"publish","type":"post","link":"https:\/\/biosafety.kz\/en\/uncategorized\/%d0%b2%d0%b8%d0%b4%d0%b5%d0%be%d0%ba%d0%be%d0%bd%d1%84%d0%b5%d1%80%d0%b5%d0%bd%d1%86%d0%b8%d1%8f-%d1%81-%d0%bc%d0%b5%d0%b4%d0%b8%d1%86%d0%b8%d0%bd%d1%81%d0%ba%d0%be%d0%b9-%d1%88%d0%ba%d0%be%d0%bb\/","title":{"rendered":"VIDEOCONFERENCE WITH DUKE-NUS SCHOOL OF MEDICINE (SINGAPORE) ON PRECLINICAL AND CLINICAL TRIALS OF THE COVID-19 VACCINE"},"content":{"rendered":"

On July 28, 2020, within the framework of international cooperation, an online video conference was held between the RSE RIBSP MES RK and the DUKE-NUS School of Medicine (Singapore). The conference was held in the format of consultations and recommendations regarding clinical and preclinical trials of COVID-19 vaccine.<\/p>\n

The online conference was attended by professors and scientists from RIBSP – Abdurayimov Ye.O., Orynbayev M.B., Kutumbetov L.B., Khairullin B.M., Sultankulova K.T., Chervyakova O.V. and etc.<\/p>\n

Dr. Ooi Eng Eong, Head of the Laboratory Research Group at DUKE-NUS School of Medicine spoke about the development process of the COVID-19 vaccine, the volume and number of doses in preclinical and clinical trials, the number of volunteers taking part in them, etc.<\/p>\n

At the end of the online conference, the parties thanked each other for the opportunity and expressed hope for further fruitful cooperation.<\/p>\n

 <\/p>\n

\"\"<\/a>","protected":false},"excerpt":{"rendered":"

On July 28, 2020, within the framework of international cooperation, an online video conference was held between the RSE RIBSP MES RK and the DUKE-NUS School of Medicine (Singapore). The conference was held in the format of consultations and recommendations regarding clinical and preclinical trials of COVID-19 vaccine. The online conference was attended by professors […]<\/p>\n","protected":false},"author":1,"featured_media":2701,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/posts\/2697"}],"collection":[{"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/comments?post=2697"}],"version-history":[{"count":3,"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/posts\/2697\/revisions"}],"predecessor-version":[{"id":2702,"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/posts\/2697\/revisions\/2702"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/media\/2701"}],"wp:attachment":[{"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/media?parent=2697"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/categories?post=2697"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/tags?post=2697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}